Riskpilot← Back to searchSign inGet full accessKIROPRAKTOR SIGRID NYVIK AS
ASActiveOrg 993593559Rikke Moksnes Vei 31A, 7506 StjørdalTraditional, complementary and alternative medicine activities · NACE 8696Est. 20091 employees
Revenue 2024
NOK 1,9M
-6% vs 2023
EBITDA margin
9.4%
-4% vs 2023
Equity ratio
62.5%
Financial strength
Net profit 2024
NOK 105K
0% vs 2023
| Revenue | NOK 1,9M | -6% |
| EBITDA | NOK 175K | -4% |
| Net profit | NOK 105K | +0% |
| Total assets | NOK 1,4M | -3% |
| Equity | NOK 897K | +13% |
| Employees | 1 | — |
Legal name
KIROPRAKTOR SIGRID NYVIK AS
Org number
993593559
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
31. januar 2009
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Selskapets virksomhet er kjøp og salg av aksjer og annen virksomhet som står i naturlig forbindelse med dette, herunder å delta i andre selskap med lignende virksomhet. Selskapet kan også ved behov levere kiropraktor-tjenester
Address
Rikke Moksnes Vei 31A, 7506 Stjørdal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 987 | 2 075 | 1 781 | 1 966 | 1 856 |
| Staff expenses | −790 | −927 | −841 | −908 | −880 |
| EBITDA | 50 | 241 | 103 | 182 | 175 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 50 | 241 | 103 | 182 | 175 |
| Net financials | −47 | −37 | −40 | −48 | −40 |
| Profit before tax | 3 | 204 | 63 | 134 | 134 |
| Tax | −0 | 20 | 14 | 30 | 29 |
| Net profit | 3 | 184 | 49 | 105 | 105 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 488 | 1 493 | 1 374 | 1 476 | 1 436 |
| Equity | 455 | 638 | 687 | 792 | 897 |
| Long-term debt | 838 | 664 | 540 | 448 | 326 |
| Short-term debt | 195 | 191 | 147 | 236 | 213 |
| Total debt | 1 033 | 855 | 686 | 684 | 539 |
EBITDA margin
9.4%
This company
15.8%
Market median
-41% vs market
20202024
Equity ratio
62.5%
This company
38.2%
Market median
+64% vs market
20202024
Return on equity
11.7%
This company
18.4%
Market median
+36% vs market
20202024
Net profit margin
5.6%
This company
8.1%
Market median
-31% vs market
20202024
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
20202024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DK Deputy Member | Deputy Member | 2009 |
SN Chief Executive Officer | Chief Executive Officer | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KIROPRAKTOR SIGRID NYVIK AS 
KIRO1 STJØRDAL ASBoard members of KIROPRAKTOR SIGRID NYVIK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Ketil Nyvik | Deputy Member | 0 companies |
| Sigrid Nyvik Prestmo | Chief Executive Officer | 0 companies |
| Erik Prestmo | Board of Directors | 0 companies |
| Brit Elin Nyvik | Board of Directors | 0 companies |